search
Back to results

Impact of TheraWorx Foam on Symptom Relief in Thumb Arthritis

Primary Purpose

Arthritis

Status
Completed
Phase
Phase 3
Locations
United States
Study Type
Interventional
Intervention
Theraworx
Placebo
Sponsored by
John Fowler
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Arthritis

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Thumb CMC arthritis
  2. greater than or equal to age 18
  3. Interested in non-operative treatment of thumb arthritis

Exclusion Criteria:

  1. Recent corticosteroid injection into the thumb joint
  2. Non-English speaking
  3. skin lesions or rashes on the thumb
  4. current use of topical anti-inflammatory medications
  5. concomitant thumb/wrist diagnoses that would impact the results (as determined by the PI)
  6. known allergy to magnesium

Sites / Locations

  • Kaufmann Building
  • Montefiore Hospital
  • University of Pittsburgh Medical Center

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Placebo Comparator

Experimental

Arm Label

Foam and Compression Wrap

Placebo Foam and Compression Wrap

Foam alone

Arm Description

Patients will use Theraworx foam and a compression wrap

Patients will use placebo foam and a compression wrap

Patients will use Theraworx foam without compression wrap

Outcomes

Primary Outcome Measures

Numeric Pain Rating Scale
patient rated pain on scale of 0-10 (0 no pain and 10 maximum pain). The mean score at 2 weeks is reported, not the change from baseline.
Disabilities of the Arm, Shoulder, and Hand (DASH) Score
patient rated outcome score on scale of 0-100, with 0 being no disability and 100 complete disability, mean value at 2 weeks is reported
Thumb Range of Motion
This measures range of motion of the thumb in degrees from 0-90 degrees (0 degrees would be no motion and 90 degrees full motion), 2 week data is presented as a mean.
Grip Strength
This measures grip strength in pounds (0 is no grip strength 150 is maximum grip strength), mean grip strength in pounds reported at 2 weeks
Pinch Strength
This measures pinch strength in pounds (0 is no pinch strength and 40 is maximum pinch strength), mean pinch in pounds reported at 2 weeks

Secondary Outcome Measures

Full Information

First Posted
December 6, 2018
Last Updated
July 13, 2021
Sponsor
John Fowler
search

1. Study Identification

Unique Protocol Identification Number
NCT03770091
Brief Title
Impact of TheraWorx Foam on Symptom Relief in Thumb Arthritis
Official Title
Impact of Theraworx Foam on Pain and Motion and Patient-Reported Outcomes in Thumb Arthritis
Study Type
Interventional

2. Study Status

Record Verification Date
July 2021
Overall Recruitment Status
Completed
Study Start Date
December 21, 2018 (Actual)
Primary Completion Date
July 30, 2020 (Actual)
Study Completion Date
August 1, 2020 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
John Fowler

4. Oversight

Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Thumb carpometacarpal osteoarthritis (CMC OA) affects up to 33% of people over the age of 40, which leads to inflammation, pain, and weakness of the CMC joint. Treatment modalities are both conservative and surgical with surgical options including osteotomy, bone excision, ligament reconstruction, and various prosthetic implants. The conservative treatment options, however, are limited to NSAIDs and bracing or steroid injections. Advances in topical therapies have the potential to deliver focused treatment to the CMC joint. Novel treatment of inflammation can potentially reduce inflammation and pain associated with progressing osteoarthritis. Theraworx Relief is an FDA registered foam that has theoretical impact on inflammation reduction in human subjects treated with the topical foam.
Detailed Description
This pilot study seeks to investigate potential benefit in the use of Theraworx Foam in patients diagnosed with thumb CMC OA. Patients presenting to the upper extremity orthopedic surgery clinic for thumb/hand/wrist pain will be diagnosed by a Board Certified Hand Surgeon as per standard protocols. Patients who are recommended to follow a conservative treatment modality and are interested in participating in this study will be randomized into treatment or control groups. Both groups will undergo symptom assessment, strength testing, and range of motion testing prior to starting the standard conservative treatment of bracing. The treatment group will use the TheraWorx topical foam and the compression wrap nightly for 2 weeks for at least 6 hours per night. Control group will use a compression wrap for the same time period. Both groups will return at 1 and 2 weeks for repeat strength and range of motion testing and symptom assessment.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Arthritis

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
40 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Foam and Compression Wrap
Arm Type
Experimental
Arm Description
Patients will use Theraworx foam and a compression wrap
Arm Title
Placebo Foam and Compression Wrap
Arm Type
Placebo Comparator
Arm Description
Patients will use placebo foam and a compression wrap
Arm Title
Foam alone
Arm Type
Experimental
Arm Description
Patients will use Theraworx foam without compression wrap
Intervention Type
Drug
Intervention Name(s)
Theraworx
Intervention Description
Theraworx foam applied to skin and/or compression wrap
Intervention Type
Drug
Intervention Name(s)
Placebo
Intervention Description
Placebo foam
Primary Outcome Measure Information:
Title
Numeric Pain Rating Scale
Description
patient rated pain on scale of 0-10 (0 no pain and 10 maximum pain). The mean score at 2 weeks is reported, not the change from baseline.
Time Frame
2 weeks
Title
Disabilities of the Arm, Shoulder, and Hand (DASH) Score
Description
patient rated outcome score on scale of 0-100, with 0 being no disability and 100 complete disability, mean value at 2 weeks is reported
Time Frame
2 weeks
Title
Thumb Range of Motion
Description
This measures range of motion of the thumb in degrees from 0-90 degrees (0 degrees would be no motion and 90 degrees full motion), 2 week data is presented as a mean.
Time Frame
2 weeks
Title
Grip Strength
Description
This measures grip strength in pounds (0 is no grip strength 150 is maximum grip strength), mean grip strength in pounds reported at 2 weeks
Time Frame
2 weeks
Title
Pinch Strength
Description
This measures pinch strength in pounds (0 is no pinch strength and 40 is maximum pinch strength), mean pinch in pounds reported at 2 weeks
Time Frame
2 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Thumb CMC arthritis greater than or equal to age 18 Interested in non-operative treatment of thumb arthritis Exclusion Criteria: Recent corticosteroid injection into the thumb joint Non-English speaking skin lesions or rashes on the thumb current use of topical anti-inflammatory medications concomitant thumb/wrist diagnoses that would impact the results (as determined by the PI) known allergy to magnesium
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
John R Fowler, MD
Organizational Affiliation
Univ. of Pittsburgh Orthopaedic Surgery
Official's Role
Principal Investigator
Facility Information:
Facility Name
Kaufmann Building
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15213
Country
United States
Facility Name
Montefiore Hospital
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15213
Country
United States
Facility Name
University of Pittsburgh Medical Center
City
Pittsburgh
State/Province
Pennsylvania
ZIP/Postal Code
15213
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Impact of TheraWorx Foam on Symptom Relief in Thumb Arthritis

We'll reach out to this number within 24 hrs